Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Arthritis Rheumatol. 2022 Mar 30;74(5):849–859. doi: 10.1002/art.42054

Table 2.

Medication use at any time point prior to echocardiogram, according to diastolic function groups.

Normal= 538 N (%) Indeterminate = 118 N (%) DD = 150 N (%) P-value
Immune Medications (ever use)
 Mycophenolate mofetil 160/537 (30) 27/116 (23) 20/148 (14) <0.001
 Methotrexate 96/537 (18) 9 (8) 18/148 (12) 0.010
 Hydroxychloroquine 132/537 (25) 20 (17) 22/148 (15) 0.016
 Cyclophosphamide 38/537 (7) 8 (7) 6/148 (4) 0.41
 Azathioprine 21/536 (4) 7/117 (6) 6/148 (4) 0.60
 Prednisone 168/536 (31) 53 (45) 49/148 (33) 0.018
Cardiovascular Medications (ever use)
 Beta blocker 57/461 (12) 19/103 (18) 36/118 (31) <0.001
 Calcium channel blocker 344/537 (64) 83/118 (70) 94/148 (64) 0.40
 ACE inhibitor 93/524 (18) 32/115 (28) 46/144 (32) <0.001
 ARB 58/457 (13) 21/99 (21) 27/115 (23) 0.005
 Diuretics 124/537 (23) 68 (58) 82/148 (55) <0.001
 Aspirin 226/537 (42) 56 (47) 79/148 (53) 0.042
 PDE5 inhibitor 91/536 (17) 37 (31) 48/148 (32) <0.001
 Endothelin receptor antagonist 26/537 (5) 19 (16) 24/148 (16) <0.001
 Prostacyclin analog 17/537 (3) 7 (6) 13/148 (9) 0.012

PDE5: phosphodiesterase 5 inhibitor; ERA: endothelin receptor antagonist